{"page_content": "Who We Are\nSocietal is a bi-coastal contract development and \nmanufacturing organization (CDMO) with capabilities \nspanning pre-Investigational New Drug (IND) development \nto commercial manufacturing and packaging for a wide \nrange of therapeutic dosage forms with a primary focus in \nthe area of small molecules. With an expertise in solving \ncomplex manufacturing problems, Societal is a leading \nCDMO providing therapeutic development, end-to-end \nregulatory support, clinical and commercial manufacturing, \naseptic fill/finish, lyophilization, packaging and logistics \nservices to the global pharmaceutical market.In addition to our experience in handling DEA controlled \nsubstances and developing and manufacturing modified-\nrelease dosage forms, Societal has the expertise to \ndeliver on our clients\u2019 pharmaceutical development and \nmanufacturing projects, regardless of complexity level. \nWe do all of this in our best-in-class facilities, totaling \n145,000 square feet, in Gainesville, Georgia, and San \nDiego, California.\n3 SocietalTM CDMO  | ESG HIGHLIGHTS REPORT 2022", "metadata": {"source": "NASDAQ_SCTL_2022.pdf", "page": 2, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}